European Web Survey on Drugs (EWSD) 2024
Introduction
On this page you can find links to outputs and resources from the European Web Survey on Drugs (EWSD) 2024. The European Web Survey on Drugs collected data between May and July 2024 from people who use drugs, aged 18 or older, living in EU and non-EU countries. Over 66 000 respondents participated across 31 countries.
As more resources become available, they will be added to this page.
Last update: 25 February 2025
Data and analysis
The following outputs from the 2024 survey are currently available.
Analysis, data and publications
- European Web Survey on Drugs 2024: top-level findings, 24 EU countries and Norway
- European Web Survey on Drugs 2024: top-level findings, Western Balkans
- European Web Survey on Drugs (EWSD) 2024: methodology
- European Web Survey on Drugs (EWSD) 2024: top-level findings and methodological information — source data
News items
About the European Web Survey on Drugs 2024
The European Web Survey on Drugs collected data between May and July 2024 from people who use drugs, aged 18 or older, living in EU and non-EU countries. Over 66 000 respondents participated across 31 countries.
Respondents were self-selected and country recruitment strategies consisted of a mixture of social media campaigns, press releases and contacts with drug-related networks. On the basis of their drug use, respondents were presented with modules on one or more of the following main substances: cannabis, cocaine, ecstasy/MDMA, amphetamine, methamphetamine, heroin, new psychoactive substances (NPS) and ketamine. Other drug modules, relevant to specific contexts, were added by individual countries. Questionnaires were presented in the languages of the countries. In EU countries the survey was a collaboration between the EUDA, Reitox national focal points and individual NGOs, and in non-EU countries between the EUDA, national contact points and NGOs. Over 100 organisations participated.